Chief Executive Officer
Tue, Nov 15, 2022
Nov 15
3,562 shares @ $0.00
Decreased holdings by -7.70%
Net across this filing: +0.20% (+2,049 shares)
34th largest trade (out of 185)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.2% (+2,049 shares)
44% win rate · -2.8% median edge vs SPY (9 trades, 90-day · small sample)
Price 38% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology